|

Heart Disease Clinical Trials in West Virginia

29 recruiting studies across 9 cities

All Trials in West Virginia

Phase
Trial Phase Location
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Bluefield
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/ACharleston
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary LesionsN/ACharleston
BoxX-NoAF Clinical TrialN/ACharleston
ELEVATE-HFpEF Clinical StudyN/ACharleston
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyN/ACharleston
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery LesionsN/ACharleston
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery LesionsN/ACharleston
SuperSaturated Oxygen Comprehensive Observational Registry—Charleston
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy—Huntington
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4Huntington
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFPhase 3Kingwood
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3Kingwood
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural PatientsN/ALewisburg
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3Martinsburg
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)—Morgantown
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityPhase 3Morgantown
Abatacept in Immune Checkpoint Inhibitor MyocarditisPhase 3Morgantown
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3Morgantown
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Morgantown
Effects of Blocking Blue Light at Night Post CABG, AVR, MVR, CABG AVR, CABG MVR, or SAHN/AMorgantown
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery LesionsN/AMorgantown
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small VesselsN/AMorgantown
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and IIIN/AMorgantown
Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse—Morgantown
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)N/AMorgantown
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—Morgantown
Product Surveillance Registry—Morgantown
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial HypercholesterolemiaPhase 3Morgantown

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.